| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |